Celebration of Science
March 15, 2013
1:00 - 6:00 pm
LSBC Seminar Room and Lobby
This is a half day symposium focused on WPI’s Life Science & Bioengineering research. Presentations will highlight new Faculty, new funding or significant new publications. The event features an opening address by Provost Overstrom and closing remarks by Dean Oates. After the presentations, a poster competition will be held along with a reception.
Neuroprosthetics 2012 SymposiumThis is the third in a series of symposia focused on Neuroprothetics. In particular the series addresses the science and engineering challenges facing the development of a new generation of implantable artificial limbs. The theme of the 2012 symposium is “Neural Interfaces as Enablers for Advanced Prosthetic Function”.
The symposium is organized by the Center for Neuroprosthetics at WPI’s Bioengineering Institute, and
will be held at Worcester Polytechnic Institute on February 23, 2012.
March 22, 2011
1:00 - 4:30 PM
(Registration begins at 12:30 p.m.)
Incubating biotechnology and medical device companies: What is the role for universities?
Developing an idea into a commercial product in the therapeutics or medical device arenas is a complex, competitive and increasingly segmented process. Start-up and emerging companies must focus on their core competencies while leveraging the expertise of service providers, alliances and partnerships to advance their technologies. There are many points of contact along the development chain where universities can, and do play important roles. At this year’s forum, speakers from WPI and a range of companies will discuss their views of the development chain and the synergies that can arise with academia.
Keynote Speaker: Morey Kraus, Chief Scientific Officer for PerkinElmer/Specialty Diagnostics
On November 3, 2010 more than 140 scientists, engineers, clinicians and advocates gathered at Worcester Polytechnic Institute for Neuroprosthetics 2010—the second annual international symposium sponsored by the Bioengineering Institute at WPI to focus on research and development of a new generation of artificial limbs that can be integrated with the body and controlled by the nervous system.
Scientific presentations on the challenges of osseointegration and soft-tissue regeneration featured speakers from the United Kingdom, Germany and the United States. Provocative keynote speeches by Kendra Calhoun, president of the Amputee Coalition of America, and Col. Jennifer Menetrez, MD, director of the Center for the Intrepid at Brooke Army Medical Center in Texas, grounded the symposium with perspectives from the amputee, both civilian and military.
The symposium was organized by the Bioengineering Institute with support from the John Adams Innovation Institute, the economic development division of the Massachusetts Technology Collaborative (MTC).
For more information contact:
Center for Neuroprosthetics
WPI Bioengineering Institute
100 Institute Road
Worcester, MA 01609-2280
At the speaker's table for >Neuroprosthetics 2009, from left, WPI President Dennis Berkey, Col. Paul Pasquina, Walter Reed Army Medical Center, and Buddy Ratner, University of Washington.
>WPI Biotechnology & Bioengineering Corporate Forum
March 23, 2010
Biomedical Informatics means different things to different people. It can and does encompass both Bioinformatics and Medical Informatics. The former, Bioinformatics, uses computational tools to explore the molecular information embedded in the human genome, proteins and signaling pathways to better understand complex biologic systems, the processes of disease, and to aid in developing new therapeutics. The latter, Medical Informatics, is the rapidly evolving field of applying information technology to clinical operations and patient care. Electronic Medical Records (EMR) is the most often cited example of this, but Medical Informatics is much broader and involves many new applications for collecting, storing, mining and managing information for a variety of clinical uses. While these are quite disparate areas of informatics, they have two things in common – they both can impact human health and they both apply sophisticated digital technologies to do so. This year’s forum will explore these aspects of Biomedical Informatics. Presenters will focus on the information technologies that companies use to produce Biomedical Informatics solutions, the challenges they encounter in developing these technologies, the customers they are working with and the problems they seek to solve.
Zhiping Weng, PhD, is professor of biochemistry & molecular pharmacology at the University of Massachusetts Medical School (UMMS) in Worcester, Massachusetts, where she is also director of the newly created Program in Bioinformatics and Integrative Biology (BIB).
With its overriding goal to educate talented and highly motivated women and men for leadership in the post-genomic era, BIB was established in 2008 to process and analyze the ever-increasing quantity of molecular information available to scientists Under Dr. Weng’s direction the program combines resources and faculty expertise in mathematics, computer science, statistics and engineering to explore and understand biological systems through the application and development of computational tools. Weng will also guide efforts to ensure that the information gathered from the sequencing of human DNA is practical and applicable for clinical research, and she will work with Graduate School of Biomedical Sciences leadership to establish a graduate training program.
Prior to coming to UMMS in 2008, Weng was associate professor of biomedical engineering at Boston University. With broad research interests including bioinformatics; DNA and protein sequence analysis; protein-protein interactions, protein structure analysis; optimization algorithms and their applications in molecular biology; and drug and vaccine design, her current investigations are focused on molecular interactions between regulatory proteins and their DNA/RNA target sites, protein-protein interaction, protein-peptide interaction and interaction between protein structure building blocks.
Weng earned her BS in Electrical Engineering in 1992 from the University of Science and Technology of China and her PhD in Biomedical Engineering at Boston University in 1997, where, after a national search, she was chosen to lead its new bioinformatics program. She has published 90 articles, including 75 peer-reviewed journal articles.
On September 16th, 2009 a very important Neuroprosthetic Symposium will be held at the Worcester Polytechnic Institute. This symposium is sponsored by the Center for Neuroprosthetics at WPI’s Bioengineering Institute (BEI). The Center for Neuroprosthetics’s mission is to successfully perform and integrate the enabling basic science and engineering necessary to achieve implantable limb prosthetics. The goal is that for amputees, these implantable neuroprosthetics will have the functional attributes of natural limbs. To promote integrated neuroprosthetics research, this Symposium will be broad in its scope with an appeal to scientific and bioengineering issues. The Symposium will bring together academic, industry and government research leaders to provide a forum for enhancing the integration of the applied science and engineering necessary to achieve functional implantable limb prosthetics.
March 25, 2009
Alliances and Partnerships in the Biotechnology & Bioengineering Industry
Getting from discovery to commercial product for new therapeutics or medical devices is an increasingly segmented process, with universities and companies focused on core-competencies along the development chain. As a result, the roles of service providers, alliances and partnerships continue to grow in scope and complexity in the pharmaceutical, biotechnology and bioengineering industries. Speakers from WPI and a range of companies will discuss their respective roles in the development chain and how they interact with other companies and universities.
Keynote Speaker: Kevin O'Sullivan, President, Massachusetts Biomedical Initiatives.
Sponsored by the WPI Bioengineering Institute and the WPI's Department of Biology and Biotechnology
October 27, 2008
To establish energy independence and insure domestic security, the United States must wean itself from petroleum-based products. Prior to World War II, plants and microorganisms provided all the materials needed for fuels and other general and specialty chemicals. It is time to return to the future and again focus on plant and microbe-based production of these chemicals to help meet our energy needs, and to create new pharmaceuticals and other chemical building blocks essential for a healthy society and environment. This Symposium will highlight new opportunities that have developed from collaborations recently initiated between the Arkansas Biosciences Institute where problems at the interface of agriculture and human health are being addressed, and Worcester Polytechnic Institute where engineering has merged with biology to solve industrial problems related to plant-produced products and biofuels.
October 8, 2008
Regenerative medicine involves the use of cells and scaffolds to produce replacement parts for the human body. This symposium will feature world renowned experts in the field of regenerative medicine, many of whom collaborate with faculty members at WPI.
March 26, 2008
Panel Session: The Challenges of Life Science Start-up Companies
The speakers in this session will describe the challenges that their young companies have encountered in the early phases of their development, how they have addressed these challenges, how the academic world has helped and how they see their company and their sector developing over the next several years.
Panel Session: New Product Development in Established Life Science Companies
The speakers in this session will describe the challenges they encounter in new product development in their established companies, how they address these challenges, how the academic world has helped, and how they see their company and sector developing over the next several years.
February 21, 2008
Nanotechnology and Micro-Electro-Mechanical Systems (MEMS) have facilitated the fabrication of minimally invasive and unobtrusive devices for physiological monitoring. In this symposium, research and development of devices with applicability in three areas will be examined; biomarker monitoring for diagnosis and drug compliance, blood glucose monitoring for diabetes management and monitoring of physical parameters such as temperature, pressure and bioelectrical signals.
>New Developments in Biomanufacturing
February 20, 2007
Advances in biomanufacturing directly impact overall product cost and quality. Incorporating recent advances in processing techniques in the manufacturing environment is a constant challenge to biologists and engineers. The WPI symposium on "New Developments in Biomanufacturing" will address some of the recent developments in a broad range of areas within the biomanufacturing field including upstream developments in bioreactors, improved filtration systems for enhanced recovery, and chromatographic recovery systems targeted for improved FDA compliance.
March 22, 2007
The Forum will provide wide-ranging perspectives on the current state of the industry and its future, and how companies, universities, and government can work together to develop new products to meet the nation's healthcare needs. We will showcase the activities of local and regional biotechnology and medical device companies as well as the research, development and commercialization efforts of WPI's Life Sciences departments and the Bioengineering Institute.
April 4, 2007
Presentations will focus on biosciences and engineering technologies at the forefront of wound healing and cardiovascular tissue regeneration.
September 20, 2007
Regenerative Biology is an emerging field within the life sciences and bioengineering disciplines which offers the ability to treat disease and or trauma by replacement of lost tissue. The regeneration of tissue involves a complex interaction between cells and their environment. Chemical, electrical and mechanical factors are all likely to play a significant role in directing cells to differentiate into desired phenotypes. By integrating principles of engineering with increased knowledge of cell biology, scientists are now beginning to understand how to use one's own cells or those from other sources to repair damaged tissue. This technology has the potential to restore function to tissues and organs that were once thought of as un-repairable. At the CRBE symposium, world renowned leaders in the field of regenerative biosciences and engineering will describe how they are able to direct the reparative process through the use of cells and engineered biomaterials.Maintained by email@example.com
Last modified: March 21, 2013 10:49:02